PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities

about

Peroxisome proliferator-activated receptor delta agonist attenuates nicotine suppression effect on human mesenchymal stem cell-derived osteogenesis and involves increased expression of heme oxygenase-1.

P2860

Q50504292-A26BFD67-2743-4850-B382-CBC2857542F1

P2860

PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities

Item

http://www.wikidata.org/entity/Q36959065

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

PPARdelta Agonism for the Trea ...... : Challenges and Opportunities

@en

type

Item

label

PPARdelta Agonism for the Trea ...... : Challenges and Opportunities

@en

prefLabel

PPARdelta Agonism for the Trea ...... : Challenges and Opportunities

@en

P1476

PPARdelta Agonism for the Trea ...... : Challenges and Opportunities

@en

P2093

David V Erbe

http://www.w3.org/2001/XMLSchema#string

James F Tobin

http://www.w3.org/2001/XMLSchema#string

Mylène Perreault

http://www.w3.org/2001/XMLSchema#string

P2860

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor

PPARdelta regulates glucose metabolism and insulin sensitivity

PPAR delta: a dagger in the heart of the metabolic syndrome.

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

Regulation of muscle fiber type and running endurance by PPARdelta

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

P304

125387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2008/125387

http://www.w3.org/2001/XMLSchema#string

P478

2008

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23456578

http://www.w3.org/2001/XMLSchema#string

P698

18989368

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

P932

2577153

http://www.w3.org/2001/XMLSchema#string

PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities

about

P2860

P2860

PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932